N/A
Completed N=135
Reducing Disparities in Medication Adherence in SLE
Source: ClinicalTrials.gov NCT03738826 ↗Enrolled (actual)
135
Serious AEs
0.0%
Results posted
Jul 2021
Primary outcomePrimary: Feasibility as Measured by Number of Participants With EMR (Electronic Medical Record) Documentation of Adherence — 116 Participants
Summary
This is a pilot study to assess the feasibility of using Surescripts refill data during the clinical encounter to improve medication adherence in patients with systemic lupus erythematosus
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility as Measured by Number of Participants With EMR (Electronic Medical Record) Documentation of Adherence |
116 | — |
| PRIMARY Acceptability as Measured by Provider Survey |
4.4 | — |
| SECONDARY Medication Adherence as Determined by Self Report |
— | — |
| SECONDARY Percentage of Adherent Participants as Determined by Medication Possession Ratio (MPR) |
46; 55 | — |
Eligibility Criteria
Inclusion Criteria
- All followup patients seen at the Duke Lupus clinic
Exclusion Criteria
- Patients not seen at the Duke Lupus Clinic
- New patients seen for the first time at the Duke Lupus Clinic
- Patients who are not prescribed any lupus medications
Data sourced from ClinicalTrials.gov (NCT03738826). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.